Cell Therapeutics, Inc. (CTIC)

Watch the video to learn about the probability of Cell Therapeutics, Inc. (CTIC) Chart Signal as of Nov 28, 2014

Hotstocked Precision will calculate the probabilities of Cell Therapeutics, Inc. (CTIC)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD
Recent Material Events for Cell Therapeutics, Inc.
Date Description
Dec 31, 2012 As set forth more fully in the Stipulation, if the settlement becomes final, among other things, (i) the claims against the Defendants will be dismissed with prejudice and released, by which the plaintiffs, the Company and its predecessors, successor
Dec 31, 2012 As set forth more fully in the Stipulation, if the settlement becomes final, among other things, (i) the claims against the Defendants will be dismissed with prejudice and released, by which the plaintiffs, the Company and its predecessors, successor
Dec 31, 2012 As previously announced by Cell Therapeutics, Inc. (the “Company”), effective as of November 15, 2012, Daniel G. Eramian separated from employment with the Company as its Executive Vice President, Corporate Communications. The Company agree
Dec 31, 2012 As previously announced by Cell Therapeutics, Inc. (the “Company”), effective as of November 15, 2012, Daniel G. Eramian separated from employment with the Company as its Executive Vice President, Corporate Communications. The Company agree
Dec 28, 2012 The information provided pursuant to this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, and sh
Dec 28, 2012 The information provided pursuant to this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, and sh
Dec 07, 2012 (e) Compensatory Arrangements of Certain Officers. On December 3, 2012, the Compensation Committee of the Board of Directors of Cell Therapeutics, Inc. (the “Company”) approved fiscal year-end cash incentive awards for 2012 for each of th
Dec 07, 2012 (e) Compensatory Arrangements of Certain Officers. On December 3, 2012, the Compensation Committee of the Board of Directors of Cell Therapeutics, Inc. (the “Company”) approved fiscal year-end cash incentive awards for 2012 for each of th
Dec 07, 2012 The amendment amends the definition of “Final Expiration Date” under the Rights Plan from the close of business on the third anniversary of January 7, 2010, or the record date, to the close of business on December 3, 2015. The amendment als
Dec 07, 2012 The amendment amends the definition of “Final Expiration Date” under the Rights Plan from the close of business on the third anniversary of January 7, 2010, or the record date, to the close of business on December 3, 2015. The amendment als

Watch the video to learn about the probability of Cell Therapeutics, Inc. (CTIC) Chart Signal as of Nov 28, 2014

This free program will calculate the probabilities of Cell Therapeutics, Inc. (CTIC) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD